News
Discovery opens door to new drug options for serious...
Researchers have discovered how oxidative stress can turn to the dark side a cellular protein that's usually benign, and make it become a powerful,...
News
HPS2-THRIVE trial: Side-effects cause a quarter of heart patients...
The largest randomised study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in...
News
FDA approves Roche’s Kadcyla (trastuzumab emtansine), the first antibody-drug...
Roche announced that the U.S. Food and Drug Administration (FDA) has approved Kadcyla (trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive...
News
Scientists unveil secrets of important natural antibiotic
An international team of scientists has discovered how an important natural antibiotic called dermcidin, produced by our skin when we sweat, is a highly...
News
Mushroom-supplemented soybean extract shows therapeutic promise for advanced prostate...
A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain...
News
New study on Hepatitis C drug treatment in vivo...
Hepatitis C virus (HCV) infection affects about 4.1 million in the United States and is the primary cause of liver cirrhosis and liver cancer....
News
ViiV Healthcare announces FDA priority review designation for dolutegravir
ViiV Healthcare announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to dolutegravir submitted for the treatment of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.